Sulotroban (SKF-95587; BM-13177) is a selective antagonist for thromboxane A2 receptor (TXA2 Receptor). Sulotroban exhibits inhibitory activity against carbocyclic thromboxane A2- and endoperoxide-induced vasoconstrictor. Sulotroban inhibits platelets aggregation.
References:
[1]. Smith III E F, et al., Sulotroban (BM 13.177)[J]. Cardiovascular Drug Reviews, 1988, 6(1): 20-34.
















